CA2011282A1 - Steroid diols, pharmaceutical compositions containing them and process for preparing same - Google Patents
Steroid diols, pharmaceutical compositions containing them and process for preparing sameInfo
- Publication number
- CA2011282A1 CA2011282A1 CA002011282A CA2011282A CA2011282A1 CA 2011282 A1 CA2011282 A1 CA 2011282A1 CA 002011282 A CA002011282 A CA 002011282A CA 2011282 A CA2011282 A CA 2011282A CA 2011282 A1 CA2011282 A1 CA 2011282A1
- Authority
- CA
- Canada
- Prior art keywords
- alpha
- hydrogen
- stands
- general formula
- dion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1156/89 | 1989-03-09 | ||
| HU891156A HU203562B (en) | 1989-03-09 | 1989-03-09 | Process for producing new steroide diols and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2011282A1 true CA2011282A1 (en) | 1990-09-09 |
Family
ID=10953088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002011282A Abandoned CA2011282A1 (en) | 1989-03-09 | 1990-03-01 | Steroid diols, pharmaceutical compositions containing them and process for preparing same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5082835A (instruction) |
| EP (1) | EP0387091A3 (instruction) |
| JP (1) | JPH06104679B2 (instruction) |
| KR (1) | KR930009445B1 (instruction) |
| CN (1) | CN1045396A (instruction) |
| AR (1) | AR244700A1 (instruction) |
| AU (1) | AU623503B2 (instruction) |
| CA (1) | CA2011282A1 (instruction) |
| EG (1) | EG19411A (instruction) |
| FI (1) | FI901199A7 (instruction) |
| HU (1) | HU203562B (instruction) |
| IL (1) | IL93478A (instruction) |
| IN (1) | IN170846B (instruction) |
| NO (1) | NO177147C (instruction) |
| PH (1) | PH26676A (instruction) |
| PT (1) | PT93375A (instruction) |
| ZA (1) | ZA901752B (instruction) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9100341D0 (sv) * | 1991-02-04 | 1991-02-04 | Astra Ab | Novel steroids |
| FR2675146A1 (fr) * | 1991-04-10 | 1992-10-16 | Roussel Uclaf | Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires. |
| AU4093799A (en) | 1998-05-22 | 1999-12-13 | Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
| ES2528403T3 (es) | 2005-04-28 | 2015-02-09 | Proteus Digital Health, Inc. | Sistemas informáticos farmacéuticos |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| CA2752373C (en) | 2009-02-20 | 2017-10-10 | To-Bbb Holding B.V. | Glutathione-based drug delivery system |
| KR20190116576A (ko) | 2009-05-06 | 2019-10-14 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| CN110078785A (zh) * | 2019-06-04 | 2019-08-02 | 博诺康源(北京)药业科技有限公司 | 一种布地奈德杂质ep-ze的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3167545A (en) * | 1959-02-07 | 1965-01-26 | Syntex Corp | 16beta-methyl-16alpha, 17 alpha-dihydroxy pregnenes and the 16alpha, 17alpha-cyclic ketals and acetals thereof |
| US3345362A (en) * | 1961-07-27 | 1967-10-03 | Lilly Co Eli | Novel pregnenolone acetonides |
| US4036831A (en) * | 1975-10-28 | 1977-07-19 | Steroid Development Company Establishment | Trimethyl siloxane steroid intermediates |
| WO1989001482A1 (en) * | 1987-08-14 | 1989-02-23 | The Upjohn Company | IMPROVED 9alpha-DEHALOGENATION PROCESS |
-
1989
- 1989-03-09 HU HU891156A patent/HU203562B/hu not_active IP Right Cessation
-
1990
- 1990-02-21 IL IL9347890A patent/IL93478A/en not_active IP Right Cessation
- 1990-02-28 IN IN185/CAL/90A patent/IN170846B/en unknown
- 1990-03-01 CA CA002011282A patent/CA2011282A1/en not_active Abandoned
- 1990-03-05 PH PH40143A patent/PH26676A/en unknown
- 1990-03-07 ZA ZA901752A patent/ZA901752B/xx unknown
- 1990-03-08 JP JP2055162A patent/JPH06104679B2/ja not_active Expired - Lifetime
- 1990-03-08 NO NO901103A patent/NO177147C/no unknown
- 1990-03-08 PT PT93375A patent/PT93375A/pt not_active Application Discontinuation
- 1990-03-08 AU AU51102/90A patent/AU623503B2/en not_active Ceased
- 1990-03-08 KR KR1019900003056A patent/KR930009445B1/ko not_active Expired - Fee Related
- 1990-03-09 FI FI901199A patent/FI901199A7/fi not_active IP Right Cessation
- 1990-03-09 EP EP19900302544 patent/EP0387091A3/en not_active Ceased
- 1990-03-09 CN CN90101248A patent/CN1045396A/zh active Pending
- 1990-03-09 AR AR90316352A patent/AR244700A1/es active
- 1990-03-09 US US07/491,683 patent/US5082835A/en not_active Expired - Fee Related
- 1990-03-11 EG EG16090A patent/EG19411A/xx active
Also Published As
| Publication number | Publication date |
|---|---|
| NO901103D0 (no) | 1990-03-08 |
| IL93478A (en) | 1994-11-11 |
| PT93375A (pt) | 1990-11-07 |
| AR244700A1 (es) | 1993-11-30 |
| JPH02279695A (ja) | 1990-11-15 |
| FI901199A0 (fi) | 1990-03-09 |
| NO901103L (no) | 1990-09-10 |
| EG19411A (en) | 1995-01-31 |
| AU623503B2 (en) | 1992-05-14 |
| ZA901752B (en) | 1991-05-29 |
| HU203562B (en) | 1991-08-28 |
| CN1045396A (zh) | 1990-09-19 |
| AU5110290A (en) | 1990-09-13 |
| KR930009445B1 (ko) | 1993-10-04 |
| PH26676A (en) | 1992-09-15 |
| JPH06104679B2 (ja) | 1994-12-21 |
| NO177147B (no) | 1995-04-18 |
| EP0387091A3 (en) | 1992-05-06 |
| EP0387091A2 (en) | 1990-09-12 |
| KR900014422A (ko) | 1990-10-23 |
| FI901199A7 (fi) | 1990-09-10 |
| US5082835A (en) | 1992-01-21 |
| NO177147C (no) | 1995-07-26 |
| IL93478A0 (en) | 1990-11-29 |
| IN170846B (instruction) | 1992-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3983233A (en) | Compositions and method of treating with stereoisomeric mixtures of 2-unsymmetrical 16,17-methylenedioxy steroids | |
| IE45023B1 (en) | Androstadiene-17-carboxylic acids and their esters | |
| JPS6140648B2 (instruction) | ||
| US4172132A (en) | 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| JPS6058999A (ja) | ステロイド系カルボン酸エステル及びこれを含有する医薬 | |
| CA2011282A1 (en) | Steroid diols, pharmaceutical compositions containing them and process for preparing same | |
| KR850001208B1 (ko) | 17α-아실옥시-5β-코르티코이드 및 17α-아실옥시-5α-코르티코이드의 제조방법 | |
| US4024131A (en) | 16-Methyl-9α-halo steroid esters, ethers and preparation thereof | |
| HU190746B (en) | Process for producing 6-alpha-methyl-corticoides and pharmaceutical compositions containing them | |
| US5053404A (en) | Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same | |
| HK16683A (en) | 21-halogenopregnane compounds | |
| AP141A (en) | Novel steroid doils. | |
| GB1594852A (en) | Derivatives of 9-chloroprednisolone | |
| US4011315A (en) | 21-acetals and mixed acetals of steroidal 21-aldehydes, intermediates and methods of preparation | |
| EP0077541B1 (de) | Delta-1,3,5-3-Chlor-11-Beta,16-Alpha,17-Alpha,21-tetra-(hydroxy)-pregnan-20-on-16,17-acetonidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| US4185101A (en) | 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| EP0000609B1 (en) | Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them | |
| GB1589585A (en) | 12a-halocorticoids | |
| JPS6150960B2 (instruction) | ||
| NO791143L (no) | 4,6-dihalogensteroider, og fremgangsmaate til deres fremstilling | |
| EP0004772A2 (en) | 4-Halo etianic acids and derivatives thereof, their pharmaceutical use and preparation | |
| PL121467B1 (en) | Process for preparing novel corticoids | |
| CS244663B2 (cs) | Způsob výroby nových derivátů 9-chlorprednisolonu | |
| CS207754B2 (cs) | Způsob výroby v poloze 17 substituovaných lljS-hydroxystcroidů substituovaných lljS-hydroxystcroidů | |
| CS202593B2 (cs) | Způsob výroby derivátů 9-fluorprednisolonu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |